Orexo AB (QX)【ORXOY】銘柄情報

Orexo AB (QX) (ORXOY) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.00

( - )

買値

1.23

売値

2.95

出来高

0.00 日の範囲 0.00

1.8001 52 週間の範囲 4.05

時価総額

69.843M

前日終値

2.00

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 42,266

発行済株式数

34,921,643

配当利回り

PER

-1.96

1 株当たり利益 (EPS)

14.98

歳入

17.8M

純利益

521.3M

Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the ... Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; Edluar for the treatment of insomnia; and Diabact UBT for the treatment of diagnosis of Helicobacter pylori. The company is developing Izipry for opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; OX390 for overdoses caused by a combination of life-threatening illicit drugs; OX125 for opioid overdose with powder-based nalmefene; OX472 for intranasal formulation of semaglutide, a GLP-1 receptor agonist, developed using proprietary AmorphOX technology; and develops thermostable and needle-free mucosal vaccines. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.orexo.com

本社

Uppsala, Sweden

設立

1994

Orexo AB (QX) is listed in the Healthcare sector of the その他OTC with ticker ORXOY. The last closing price for Orexo AB (QX) was US$2. Over the last year, Orexo AB (QX) shares have traded in a share price range of US$ 1.8001 to US$ 4.05.

Orexo AB (QX) currently has 34,921,643 shares in issue. The market capitalisation of Orexo AB (QX) is US$69.84 million. Orexo AB (QX) has a price to earnings ratio (PE ratio) of -1.96.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0.1999	11.1049386145	1.8001	2	1.8001	550	1.98182727	DR
12	-0.65	-24.5283018868	2.65	2.65	1.8001	217	1.99154615	DR
26	-0.6	-23.0769230769	2.6	2.65	1.8001	142	2.0481799	DR
52	0.01	0.502512562814	1.99	4.05	1.8001	218	2.46232138	DR
156	0.59	41.8439716312	1.41	4.05	0.889	626	1.74797683	DR
260	-2.52	-55.7522123894	4.52	4.65	0.76	606	1.90178094	DR